Hussman Strategic Advisors, Inc. Biocept Inc Put Options Transaction History
Hussman Strategic Advisors, Inc.
- $386 Million
- Q3 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
About BIOCEPT INC
- Ticker BIOC
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,922,900
- Market Cap $1.18M
- Description
- Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...